A review of emerging tyrosine kinase inhibitors as durable treatment of neovascular age-related macular degeneration
Expert Opin Emerg Drugs. 2023 Dec;28(3):203-211. doi: 10.1080/14728214.2023.2259790. Epub 2023 Oct 12.ABSTRACTINTRODUCTION: Current treatment for age-related macular degeneration poses a large burden on patients and the inability of patients to adhere to this immense burden can lead to worse visual outcomes. Novel treatments have been proposed to extend treatment intervals and reduce visit burden.AREAS COVERED: This review article summarizes phase I and phase II clinical trials of tyrosine kinase inhibitors as durable treatment options for patient with neovascular age-related macular degeneration.EXPERT OPINION: Tyrosine k...
Source: Expert Opinion on Emerging Drugs - October 5, 2023 Category: Drugs & Pharmacology Authors: Nikhil Das Sameer Chaurasia Rishi P Singh Source Type: research
A review of emerging tyrosine kinase inhibitors as durable treatment of neovascular age-related macular degeneration
Expert Opin Emerg Drugs. 2023 Oct 5:1-9. doi: 10.1080/14728214.2023.2259790. Online ahead of print.ABSTRACTINTRODUCTION: Current treatment for age-related macular degeneration poses a large burden on patients and the inability of patients to adhere to this immense burden can lead to worse visual outcomes. Novel treatments have been proposed to extend treatment intervals and reduce visit burden.AREAS COVERED: This review article summarizes phase I and phase II clinical trials of tyrosine kinase inhibitors as durable treatment options for patient with neovascular age-related macular degeneration.EXPERT OPINION: Tyrosine kina...
Source: Expert Opinion on Emerging Drugs - October 5, 2023 Category: Drugs & Pharmacology Authors: Nikhil Das Sameer Chaurasia Rishi P Singh Source Type: research
How can we prevent diarrhea induced by systemic treatments in oncological patients? An evaluation of phase II trials
Expert Opin Emerg Drugs. 2023 Sep 26:1-4. doi: 10.1080/14728214.2023.2264182. Online ahead of print.NO ABSTRACTPMID:37750491 | DOI:10.1080/14728214.2023.2264182 (Source: Expert Opinion on Emerging Drugs)
Source: Expert Opinion on Emerging Drugs - September 26, 2023 Category: Drugs & Pharmacology Authors: Andrea Esposito Paolo Bossi Source Type: research
